150 related articles for article (PubMed ID: 12718407)
1. A cell-based model of HCV-negative-strand RNA replication utilizing a chimeric hepatitis C virus/reporter RNA template.
King RW; Zecher M; Jeffries MW; Carroll DR; Parisi JM; Pasquinelli C
Antivir Chem Chemother; 2002 Nov; 13(6):353-62. PubMed ID: 12718407
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.
King RW; Zecher M; Jefferies MW
Antivir Chem Chemother; 2002 Nov; 13(6):363-70. PubMed ID: 12718408
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
[TBL] [Abstract][Full Text] [Related]
4. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
5. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
Kim M; Shin D; Kim SI; Park M
Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
[TBL] [Abstract][Full Text] [Related]
7. Properties of hepatitis C virus minigenome containing mutated 5'UTR region and luciferase transgene.
Yang J; Lei YF; An QX; Yin W; Lu X; Ye L; Wei SH; Jia Z; Xu ZK
Acta Virol; 2010; 54(2):105-12. PubMed ID: 20545439
[TBL] [Abstract][Full Text] [Related]
8. Template requirements and binding of hepatitis C virus NS5B polymerase during in vitro RNA synthesis from the 3'-end of virus minus-strand RNA.
Astier-Gin T; Bellecave P; Litvak S; Ventura M
FEBS J; 2005 Aug; 272(15):3872-86. PubMed ID: 16045758
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.
Smolic R; Smolic M; Andorfer JH; Wu CH; Smith RM; Wu GY
World J Gastroenterol; 2010 May; 16(17):2100-8. PubMed ID: 20440850
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.
Krieger N; Lohmann V; Bartenschlager R
J Virol; 2001 May; 75(10):4614-24. PubMed ID: 11312331
[TBL] [Abstract][Full Text] [Related]
11. Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.
Ahn DG; Shim SB; Moon JE; Kim JH; Kim SJ; Oh JW
J Viral Hepat; 2011 Jul; 18(7):e298-306. PubMed ID: 21692941
[TBL] [Abstract][Full Text] [Related]
12. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase.
Cai Z; Yi M; Zhang C; Luo G
J Virol; 2005 Sep; 79(18):11607-17. PubMed ID: 16140738
[TBL] [Abstract][Full Text] [Related]
14. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system.
Bost AG; Venable D; Liu L; Heinz BA
J Virol; 2003 Apr; 77(7):4401-8. PubMed ID: 12634397
[TBL] [Abstract][Full Text] [Related]
15. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
[TBL] [Abstract][Full Text] [Related]
17. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
18. Efficient initiation of HCV RNA replication in cell culture.
Blight KJ; Kolykhalov AA; Rice CM
Science; 2000 Dec; 290(5498):1972-4. PubMed ID: 11110665
[TBL] [Abstract][Full Text] [Related]
19. Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.
Wang L; Jeng KS; Lai MM
J Virol; 2011 Aug; 85(16):7954-64. PubMed ID: 21632751
[TBL] [Abstract][Full Text] [Related]
20. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
